###### What is already known on this topic?

Characteristics of infants admitted to neonatal intensive care units differ, and comparing unadjusted mortality rates should be avoided.

###### What this study adds?

-   Logistic regression derived risk-adjusted mortality rates plotted on funnel plots provide a powerful visual graphical tool for presenting quality performance data.

-   Centre-to-centre variation is readily identified, permitting hospitals to appraise their practices and start timely intervention.

Background {#s1}
==========

Advances in perinatal and neonatal care have significantly reduced neonatal mortality rates, especially among preterm and low birth weight infants.[@R1] However, there is significant centre-to-centre (CTC) variation in mortality rates among neonatal intensive care units (NICUs).[@R2] Studying CTC variation in mortality rates is important because inferences about quality of care can be made which permit changes in practice to improve outcomes.[@R13] However, comparisons between hospitals can be misleading unless there is adjustment for differences in population characteristics and severity of illness.

Our aim was to report the risk-adjusted CTC variation in mortality rates for infants born at \<32 weeks and admitted to all eight tertiary NICUs in the New South Wales (NSW) and the Australian Capital Territory (ACT) Neonatal Network (NICUS), Australia. Furthermore, we would like to show the benefits of adjusting CTC variation for population characteristics. NSW is the most populous state of Australia,[@R14] and the ACT, home to the Government of the Commonwealth, is within NSW.

Methods {#s2}
=======

We analysed prospectively collected data from a geographically defined area. All infants who were delivered before 32 weeks of gestational age and admitted to one of the eight tertiary perinatal centres in NSW and the ACT between 1 January 2007 and 31 December 2014 were included in the study. Full descriptions of the NSW and ACT neonatal service organisation and networking, medical and nursing staffing of the collaborating NICUs are available elsewhere.[@R15] Geographically, the ACT lies within NSW and the state and territory combined have a total population of 7904500 with approximately 106 007 live births per year.[@R19]

Data source {#s3}
===========

Data for this study were obtained from The Neonatal Intensive Care Units' Data Collection, which is an ongoing prospective state and territory wide audit of infants admitted to all eight perinatal centres and two children's hospitals in NSW and the ACT for one of the following reasons: (1) gestation 22^+0^ to 31^+6^ weeks; (2) birth weight ≤1500 g; (3) assisted ventilation (mechanical ventilation, continuous positive airway pressure, high flow humidified gas); (4) major surgery (opening of a body cavity); and/or (5) insertion of a central line, exchange transfusion and/or therapeutic hypothermia. Definitions and accuracy of the database have been described elsewhere.[@R20] In Australia, it has been recommended by the National Health and Medical Research Council that wherever possible preterm birth at \<33 weeks should occur in a perinatal centre that has the expertise to care for the woman and her preterm infant.[@R21] In general, preterm infants born at \<32 weeks in non-tertiary hospitals are transferred to tertiary centres by means of the Newborn and Paediatric Emergency Transport Service, a transport organisation that functions across the NSW/ACT region.[@R16] Data from two tertiary children's hospitals were not included in this study due to the low patient load (n=11) as retrieved premature infants were preferentially admitted to the eight perinatal centres instead of the two paediatric hospitals.[@R18]

Outcome measure {#s3a}
---------------

The study outcome was hospital mortality (death before discharge home). The principal causes of death were coded using the International Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification.[@R22]

Because some conditions, seizures for example, are rarely the principal cause of death, we used a composite neonatal adverse outcome indicator (NAOI). NAOI has been validated previously.[@R23]

Statistical analysis {#s3b}
--------------------

Statistical analyses were performed using *SPSS* (IBM, IBM SPSS Statistics for Windows, V22.0.0.0. Released 2013).

We performed a stepwise multiple logistic regression elimination analysis to establish the independent risk factors associated with mortality, after controlling for *significant* confounding factors (eg, ethnicity) in addition to other predictors (eg, gestational age) identified in other studies. In this multivariate model, we controlled for antenatal and perinatal variables but not *intermediate* variables (eg, intraventricular haemorrhage, retinopathy of prematurity, necrotising enterocolitis, chronic lung disease), as these may be related, directly or indirectly, to the quality of the management and might thus act as *intermediate* comorbidities through which the effect of 'hospital' is mediated.[@R24]

We used the multiple logistic regression to estimate the probability of hospital mortality after adjusting for potential confounding factors. Calibration was determined by means of Hosmer-Lemeshow goodness-of-fit χ[@R2] test (high p value suggests better classification).[@R25] The ability of the logistic regression model to discriminate between those who died in hospital and those who survived until discharge was summarised using the C-statistic. A C-statistic of 0.5 indicates that the model discriminates no better than chance alone, whereas a value of 1.0 indicates perfect discrimination.[@R26]

The probabilities of death within an NICU were summed to give the hospital's expected rate of death. Risk-adjusted standardised mortality ratios (SMRs) for each hospital were then produced by dividing the observed number of hospital deaths by the expected number produced by the logistic regression model. The 95% CIs for SMR were calculated by using Miettinen's modification as described by Rothman *et al*.[@R28] The SMRs were used to calculate the adjusted mortality rates for each hospital.

We used funnel plots to provide visual indication to differentiate between two sources of variation, namely common-cause and special-cause variation, of risk-adjusted hospital mortality among NICUs.[@R29] These plots test whether the rate of mortality of an NICU differs significantly from the network average rate, assuming only random sampling variation rather than bias influences the NICU's rate. The overall network mortality rate is represented by a solid horizontal line while the ±95% (2σ) and ±99.8% (3σ) control limits are represented by the curved dotted lines. Assuming differences arise from random sampling variation alone, the chance of the hospital being within the limits is 95% for the inner funnel and 99.8% for the outer funnel.

The level of statistical significance for all analyses was set at p\<0.05 using two-tailed comparisons. The significance level was not changed when multiple comparisons were performed.

Results {#s4}
=======

A total of 7212 live born infants \<32^+0^ weeks gestation were admitted consecutively to one of the eight tertiary perinatal centres during the study period. Maternal and neonatal characteristics stratified by admitting hospital are shown in [tables 1 and 2](#T1 T2){ref-type="table"}.

###### 

Maternal characteristics of the study group stratified by admitting hospital A to H

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                       A\                 B\                 C\             D\             E\             F\             G\             H\             All\
                                       (n=1225)           (n=1000)           (n=963)        (n=889)        (n=856)        (n=848)        (n=785)        (n=646)        (n=7212)
  ------------------------------------ ------------------ ------------------ -------------- -------------- -------------- -------------- -------------- -------------- ------------------
  Maternal age, years                  29.0(24.0--33.0)   30.0(26.0--35.0)   29.0\          32.0\          32.0\          32.0\          29.0\          30.0\          30.0(26.0--35.0)
                                                                             (25.0--34.0)   (28.0--36.0)   (27.0--36.0)   (28.0--36.0)   (24.0--33.0)   (26.0--34.0)   

  Indigenous Australian                129 (10.5)         34 (3.4)           39 (4.0)       38 (4.3)       43 (5.0)       24 (2.8)       70 (8.9)       49 (7.6)       426 (5.9)

  Assisted conception                  105 (8.6)          156 (15.6)         104 (10.8)     136 (15.3)     129 (15.1)     141 (16.6)     77 (9.8)       73 (11.3)      921 (12.8)

  Multiple pregnancy                   338 (27.6)         271 (27.1)         276 (28.7)     279 (31.4)     251 (29.3)     244 (28.8)     185 (23.6)     205 (31.7)     2049 (28.4)

  Hypertension in pregnancy            231 (18.9)         216 (21.6)         143 (14.8)     202 (22.7)     165 (19.3)     153 (18.0)     157 (20.0)     121 (18.7)     1388 (19.2)

  Chorioamnionitis                     161 (13.1)         293 (29.3)         229 (23.8)     152 (17.1)     297 (34.7)     232 (27.4)     111 (14.1)     219 (34.0)     1694 (23.5)

  Intrauterine growth restriction      145 (11.8)         158 (15.8)         123 (12.8)     166 (18.7)     143 (16.7)     124 (14.6)     100 (12.7)     84 (13.0)      1043 (14.5)

  Antenatally diagnosed malformation   19 (1.6)           27 (2.7)           20 (2.1)       34 (3.8)       4 (0.5)        10 (1.2)       9 (1.1)        20 (3.1)       143 (2.0)

  Any antenatal steroids               1119 (91.3)        849 (84.9)         885 (91.9)     822 (92.5)     805 (94.0)     780 (92.0)     712 (90.7)     588 (91.0)     6560 (91.0)

  Vaginal breech delivery              82 (6.7)           84 (8.4)           63 (6.5)       54 (6.1)       28 (3.3)       34 (4.0)       36 (4.6)       39 (6.0)       420 (5.8)

  Caesarean section                    681 (55.6)         594 (59.4)         561 (58.3)     578 (65.0)     601 (70.2)     551 (65.0)     517 (65.9)     385 (59.6)     4468 (62.0)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as median (IQR) for maternal age and *n* (%) for all other variables. Chorioamnionitis includes clinically suspected as well as pathologically proven cases.

###### 

Neonatal characteristics of the study group stratified by admitting hospital A to H

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                        A\                     B\                       C\                       D\                       E\                         F\                       G\                       H\                       All\
                                        (n=1225)               (n=1000)                 (n=963)                  (n=889)                  (n=856)                    (n=848)                  (n=785)                  (n=646)                  (n=7212)
  ------------------------------------- ---------------------- ------------------------ ------------------------ ------------------------ -------------------------- ------------------------ ------------------------ ------------------------ ------------------------
  Onsite surgical support               Yes                    No                       No                       Yes                      No                         No                       No                       Yes                      --

  Born in non-tertiary hospital         155 (12.7)             89 (8.9)                 97 (10.1)                94 (10.6)                78 (9.1)                   99 (11.7)                74 (9.4)                 61 (9.4)                 747 (10.4)

  Male gender                           687 (56.1)             531 (53.1)               501 (52.0)               481 (54.1)               460 (53.7)                 478 (56.4)               409 (52.1)               345 (53.4)               3892 (54.0)

  Gestational age, week\*               29.0 (27.0--31.0)      29.0 (27.0--30.0)        29.0 (27.0--31.0)        29.0 (27.0--30.0)        29.0 (27.0--30.0)          29.0 (27.0--30.0)        29.0 (27.0--31.0)        29.0 (27.0--31.0)        30.0 (29.0--31.0)

  Birth weight, g\*                     1270 (960.0--1550.0)   1200.0 (910.0--1494.0)   1240.0 (938.0--1536.0)   1235.0 (940.0--1547.0)   12 250.0 (960.0--1520.0)   1220.0 (930.0--1502.0)   1260.0 (960.0--1559.0)   1290.0 (980.0--1550.0)   1240.0 (950.0--1530.0)

  Birth weight\<10th percentile         82 (6.7)               99 (10.0)                72 (7.5)                 60 (6.8)                 72 (8.5)                   69 (8.2)                 57 (7.3)                 50 (7.8)                 561 (7.8)

  Head circumference\<10th percentile   47 (3.9)               26 (2.8)                 34 (4.0)                 47 (5.5)                 33 (4.1)                   31 (3.8)                 25 (3.4)                 22 (3.4)                 265 (3.9)

  Apgar score\<7 at 5 min               213 (17.5)             218 (21.9)               211 (22.0)               173 (19.5)               191 (22.4)                 158 (18.7)               140 (17.9)               156 (24.2)               1460 (20.3)

  Surfactant                            642 (52.4)             741 (74.1)               509 (52.9)               534 (60.1)               572 (66.8)                 516 (60.8)               580 (73.9)               373 (57.7)               4467 (61.9)

  Postnatal steroids                    32 (2.6)               66 (6.6)                 62 (6.4)                 82 (9.2)                 54 (6.3)                   69 (8.1)                 59 (7.5)                 44 (6.8)                 468 (6.5)
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Other than for onsite surgical support data are presented as median (IQR)\* or *n* (%).

The proportion of pregnancies and deliveries involving maternal hypertension, multiple birth, caesarean section and Apgar score \<7 at 5 min varied between hospitals. Antenatal steroid was administered to 84.9% to 94.0% of neonates ([table 1](#T1){ref-type="table"}). Overall, 10.4% of the study population was born in non-tertiary hospitals (outborn). Median gestation at birth and birth weight were similar between hospitals ranging from 27 to 31 completed weeks and 910.0 to 1559.0 g, respectively. Use of surfactant and postnatal steroid showed higher variability between hospitals ([table 2](#T2){ref-type="table"}).

Observed and expected mortality and SMR {#s4a}
---------------------------------------

The observed and expected mortality and SMR stratified by admitting hospital are shown in [table 3](#T3){ref-type="table"}. The overall hospital mortality rate was 7.9% (n=572 deaths), and SMR was 1.02 (95% CI 0.94 to 1.11) ([table 3](#T3){ref-type="table"}). Hospital mortality rate varied from 5.3% in hospital E to 10.4% in hospital C. Similarly, expected mortality, SMR and risk-adjusted mortality varied between hospitals ([table 3](#T3){ref-type="table"}).

###### 

Neonatal mortality of the study group stratified by admitting hospital A to H

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Hospital                       A\                  B\                  C\                  D\                  E\                  F\                  G\                  H\                  All\
                                 (n=1225)            (n=1000)            (n=963)             (n=889)             (n=856)             (n=848)             (n=785)             (n=646)             (n=7212)
  ------------------------------ ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  Observed mortality             107 (8.7)           69 (6.9)            100 (10.4)          71 (8.0)            45 (5.3)            69 (8.1)            63 (8.0)            48 (7.4)            572 (7.9)

  Expected mortality             94 (7.7)            89 (8.9)            83 (8.6)            70 (7.8)            58 (6.7)            63 (7.4)            56 (7.2)            47 (7.3)            560 (7.8)

  Standardised mortality ratio   1.14 (0.94--1.37)   0.77 (0.61--0.97)   1.21 (0.98--1.46)   1.06 (0.84--1.32)   0.78 (0.57--1.03)   1.10 (0.86--1.38)   1.12 (0.87--1.43)   1.02 (0.76--1.34)   1.02 (0.94--1.11)

  Risk-adjusted mortality        110 (9.0)           61 (6.1)            92 (9.6)            72 (8.1)            53 (6.2)            74 (8.7)            69 (8.8)            52 (8.1)            584 (8.1)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as *n* (%) (95% CI). Expected hospital mortality was calculated using a multiple logistic regression model adjusted for ethnicity, assisted conception, multiple gestation, hypertensive disease of pregnancy, antenatally diagnosed malformation, chorioamnionitis, any antenatal steroids, outborn, method of birth, gender, gestational age, birth weight percentiles, Apgar score \<7 at 5 min and postnatal steroid.

[Figure 1](#F1){ref-type="fig"} shows the observed mortality rates for all admitting hospitals stratified by gestational age at birth. Hospital C and E exceeded the +99.8% and −99.8% limits, respectively (figure 1A). When mortality was stratified by gestation, hospital C approached the +95% control limit for infants born at 23--26 weeks of gestation (figure 1B).

![Funnel plot showing observed mortality rates in neonatal intensive care units in New South Wales and Australian Capital Territory between 2007 and 2014 for infants born at 23 to 31 (A), 23 to 26 (B), 27 to 28 (C) and 29 to 31 (D) weeks of gestation. Average, 95% and 99.8% lower and upper control limits are shown.](fetalneonatal-2017-313222f01){#F1}

[Figure 2](#F2){ref-type="fig"} shows the risk-adjusted mortality rates for all admitting hospitals stratified by gestational age at birth. No hospital exceeded the ±99.8% control limits. Hospital C approached the +95% control limit for infants born at 23--31 weeks of gestation (figure 2A). Hospital B and E showed better outcome (ie, exceeding −95% control limit) for infants born at 23--31 weeks of gestation ([figure 2A](#F2){ref-type="fig"}).

![Funnel plot showing risk-adjusted hospital mortality in neonatal intensive care units in New South Wales and Australian Capital Territory for infants born at 23 to 31 (A), 23 to 26 (B), 27 to 28 (C) and 29 to 31 (D) weeks of gestation. Average, 95% and 99.8% lower and upper control limits are shown.](fetalneonatal-2017-313222f02){#F2}

Predictors of mortality {#s4b}
-----------------------

Lack of antenatal steroid, antenatally diagnosed malformation, mode of birth, male gender, lower gestation, lower birth weight, Apgar score \<7 at 5 min and lack of postnatal steroid were significant risk factors for mortality (online [supplementary table S1](#SP1){ref-type="supplementary-material"}). Of note is that postnatal steroid effect changed from unadjusted to the adjusted model. Postnatal steroid was associated with improved survival once other neonatal factors were adjusted for.

10.1136/archdischild-2017-313222.supp1

Validation of the logistic regression model {#s4c}
-------------------------------------------

The logistic regression model used to calculate expected mortality shown in [table 3](#T3){ref-type="table"} showed an adequate overall discrimination with a C-statistic (SE) of 0.86 (0.01) (95% CI 0.84 to 0.87). The model fitted the data well (goodness-of-fit χ^2^ (7df)=5.828; p=0.560).

Causes of death {#s4d}
---------------

The most common causes of death are listed in (online [supplementary table S2](#SP2){ref-type="supplementary-material"}). Intracerebral and grades 3 and 4 intraventricular haemorrhage (136, 23.8%), sepsis (128, 22.4%), respiratory distress syndrome (85, 14.9%) and necrotising enterocolitis (61, 10.7%) were the most common causes of death.

10.1136/archdischild-2017-313222.supp2

Discussion {#s5}
==========

There is a growing demand for accurate measures of performance variation between hospitals nationally and internationally. However, there is no consensus on what performance indicators should be monitored and how performance is best measured.[@R30]

This study showed that there is little CTC variability in mortality across NICUS Network, Australia. Overall, mortality rates were similar when case mix, severity of illness and number of admissions (NICU volume) were taken into consideration ([figure 2](#F2){ref-type="fig"}).

Ongoing benchmarking of performance is critical for implementation and evaluation of quality improvement initiatives. Within neonatal networks, studying benchmarking results may help address significant variations within the network. This could be simplified by using adjusted measures and funnel plots as we have done. Funnel plots are a simple and powerful graphical method for discriminating between two types of variations. Variation between the units is categorised according to the action needed to reduce it,[@R31] thereby guiding the appropriate action.[@R32] Process variation is of two types: *common* (chance) and *special* (assignable) causes of variation. *Common-cause variation*, which is shown as data within the control limits of the chart, is intrinsic to the process. Reduction of common-cause variation requires fundamental changes in the underlying process.[@R31] *Special-cause variation*, which is shown as out-of-control signals in the chart (ie, data point outside the ±99.8% limit), is the result of factors extrinsic to the process, and its reduction therefore requires identification of and action on the special causes.[@R31] Opportunities for improvement in infrastructure and clinical practice could be drawn from hospitals operating below the lower −99.8% limit. In our study, no hospital showed special-cause variation. Detailed framework for improvement using process control is discussed elsewhere.[@R34]

Another advantage of using funnel plots is to use the +95% (2σ) control limits to encourage further investigation. Hospitals exceeding this limit should start early quality improvements to make sure the outcome does not become out of control. Similarly, opportunities for improvement in infrastructure and clinical practice could be drawn from hospitals operating below the lower −95% limit.

CTC variation similar to that which we observed has been reported from other countries including the USA and UK, Canada, Germany, Finland, Switzerland and Japan.[@R2] The causes of this variation are difficult to ascertain from this study and deserve further consideration. However, others have suggested that variation could be related to illness severity, different attitudes and thresholds to limiting or withdrawing intensive care measures[@R11] or different management styles among NICUs.[@R2]

This study has substantial strengths. It is one of the larger NICU network reports using validated data[@R35] with standardised published definitions.[@R36] All data were coded prospectively, enhancing reliability and accuracy. Our statistical approach is robust as it took case mix and NICU volume into consideration. Our data lacked certain information pertinent to neonatal outcomes, such as fetal compromise[@R37] and sociocultural factors.[@R38] Consequently, there is likely to be some residual confounding despite the high discrimination and goodness of fit of the logistic regression model. Delivery room deaths were not included in our database so we could not detect interhospital variation or determine causes for these deaths. Another limitation is that the maternal record is entered multiple times for 'multiple and higher order infants'. Therefore, mothers of more than one premature neonate within the study frame appear more than once in [table 1](#T1){ref-type="table"} and the number of mothers and neonates is equal (7212). As the data are de-identified, we are unable to account for this. But we believe, particularly given relatively low parity in Australia, that the number of mothers included more than once would be small in the 7-year study period.

Conclusion and policy implications {#s6}
==================================

Our data showed trends of risk-adjusted CTC mortality variation with a large NICU network. Centre-specific factors other than differences in baseline demographics and NICU volume may be involved. There is an urgent need to delineate these factors. The approach presented in our paper should form the basis for action on neonatal mortality variation and could easily be employed in real or near real time to detect variation early to facilitate timely interventions. In addition, there is a need to study variation in the main morbidities and neurodevelopmental outcomes between these hospitals.
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